The Bloomberg Baystate Business Hour: Balloons and Robots
BLOOMBERG – Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Anne Mostue are joined by top names from local business and finance to medicine and politics, along with Bloomberg reporters covering the latest stories in and around Boston.
This Company Raised $27 Million for a Weight Loss Balloon You Can Swallow in a Pill
FORTUNE – Beyond diet and exercise, Americans who need to lose significant weight—whether to guard against diabetes, heart disease, or other obesity-related illnesses—don’t have a lot of ideal options. Bariatric surgery is invasive, risky, and expensive.
Allurion Raises $27 Million for Weight-Loss Tech
WSJ – Startup’s balloon-based system delivers weight loss without surgery
Swallowable gastric balloon could help the obese lose weight without surgery
THE GUARDIAN – Although not a replacement for bariatric surgery, temporary balloon could be used as early intervention or for those who do not want, or cannot have, surgery
Allurion Repays Massachusetts Life Sciences Center
MLSC – The Massachusetts Life Sciences Center (MLSC) and Natick-based Allurion Technologies announced that the company, which was awarded a $750,000 Accelerator loan from the MLSC in 2011, has repaid the loan with interest after a successful funding round from private investors.
VIDEO – Balloon You Can Swallow Fights Obesity
NBC NEWS – Could a ‘Balloon in a Pill’ Be the Next Weight Loss Weapon?
More Data on Balloon-in-a-Pill Show Almost 15% Weight Loss
MEDSCAPE – Results from another small trial with a novel intragastric balloon that can be swallowed without the patient requiring endoscopy or anesthesia show that the 42 participants lost an average of 15.6 kg (34 lb), or over 14% of their body weight, over the 16-week duration of the trial.
The patients involved in the study had an average BMI of 38.6 kg/m2 at the start of the study and in this case were put on a ketogenic, very low-calorie diet (700 kcal/day) diet for the last 4 weeks of the trial.